Lataa...
Oncolytic virus-mediated targeting of PGE(2) in the tumor alters the immune status and sensitizes established and resistant tumors to immunotherapy
Immunotherapies are highly promising cancer treatments, but understanding the factors mediating their resistance remains critical. Successes in randomized clinical testing have supported the growing appreciation that oncolytic virotherapies primarily act as immunotherapies. Here we identified prosta...
Tallennettuna:
| Julkaisussa: | Cancer Cell |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4962335/ https://ncbi.nlm.nih.gov/pubmed/27374223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2016.05.012 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|